Showing 1-14 of 14 results for "

PRS3363

"
Yaju Duan et al.
Cytokine, 119, 159-167 (2019-03-27)
Immune cells infiltrating the psoriatic skin secrete high amounts of pro-inflammatory cytokines IL-17, TNF-α, IL-21 and IL-36 resulting in chronic inflammation. However, the exact cellular and molecular mechanisms have not been fully understood. We report here elevation of IL-33 expression...
Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice
Sedhom MA, et al.
Gut, 62(12), 1714-1723 (2013)
Salma Begum et al.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, 68(4), 253-267 (2020-02-29)
Interleukin-33 (IL-33) is an IL-1 family cytokine with pleiotropic effects on diverse cell types. Dysregulated IL-33 signaling has been implicated in pregnancy-related disorders, including preeclampsia and recurrent pregnancy loss, and in ovarian function in women undergoing controlled ovarian stimulation for...
IL?33 restricts invasion and adhesion of trophoblast cell line JEG3 by downregulation of integrin ?4?1 and CD62L
Wang XH, et al.
Molecular Medicine Reports, 16(4), 3887-3893 (2017)
Chengchuang Zhan et al.
Life sciences, 267, 118984-118984 (2021-01-01)
An increase in oxidative stress is an important pathological mechanism of heart injury induced by doxorubicin (DOX). Tranilast is an anti-allergy drug that has been shown to possess good antioxidant activity in previous studies. The overexpression and secretion of chymase...
IL-33 enhances proliferation and invasiveness of decidual stromal cells by up-regulation of CCL2/CCR2 via NF-?B and ERK1/2 signaling.
Hu WT
Molecular Human Reproduction, 20(4), 358-372 (2014)
ST2L Transmembrane Receptor Expression: An Immunochemical Study on Endarterectomy Samples
Marzullo A, et al.
PLoS ONE, 11(5) (2016)
The IL-33/ST2 pathway contributes to intestinal tumorigenesis in humans and mice
Mertz KD, et al.
Oncoimmunology, 5(1) (2015)
Mark Barbour et al.
Journal of neuroimmunology, 318, 87-96 (2018-03-13)
Experimental autoimmune encephalomyelitis (EAE) mice were administered with murine anti-CD52 antibody to investigate its therapeutic effect and whether the treatment modulates IL-33 and ST2 expression. EAE severity and central nervous system (CNS) inflammation were reduced following the treatment, which was...
Interleukina?`33 expression in ovarian cancer and its possible suppression of peritoneal carcinomatosis.
Sekiya, et al.
International Journal of Oncology, 55, 755-765 (2020)
Xiao-Hui Wang et al.
Molecular medicine reports, 16(4), 3887-3893 (2017-08-03)
Interleukin-33 (IL-33) promotes migration of cancer cells through downregulating the expression of E-cadherin. Previous studies have demonstrated that IL‑33 stimulates the proliferation of trophoblasts. However, the effect of IL‑33 on the adhesion and invasion of trophoblasts has not been investigated...
Mamdouh A K Sedhom et al.
Gut, 62(12), 1714-1723 (2012-11-23)
Inflammatory bowel diseases (IBD) have been intrinsically linked to a deregulated cytokine network, but novel therapeutic principles are urgently needed. Here we identify the interleukin (IL)-33 and its receptor ST2 as key negative regulators of wound healing and permeability in...
Kirsten D Mertz et al.
Oncoimmunology, 5(1), e1062966-e1062966 (2016-03-05)
Colorectal cancer (CRC) develops through a multistep process and is modulated by inflammation. However, the inflammatory pathways that support intestinal tumors at different stages remain incompletely understood. Interleukin (IL)-33 signaling plays a role in intestinal inflammation, yet its contribution to...
Wen-Ting Hu et al.
Molecular human reproduction, 20(4), 358-372 (2013-12-18)
Interleukin (IL)-33, a newly described member of the IL-1 family, has been reported to facilitate primary tumor progression and metastatic dissemination. However, its biological function on decidual stromal cells (DSCs) remains unclear. In this study, we tested the hypothesis whether...